These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2531949)

  • 1. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro.
    Kerr PG; Atkins RC
    Transplantation; 1989 Dec; 48(6):1048-52. PubMed ID: 2531949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1989 May; 42(5):788-94. PubMed ID: 2524464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells.
    Kerr PG; Atkins RC
    Immunol Cell Biol; 1991 Jun; 69 ( Pt 3)():177-83. PubMed ID: 1835710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes.
    Hoeger PH; Tepper MA; Faith A; Higgins JA; Lamb JR; Geha RS
    J Immunol; 1994 Nov; 153(9):3908-16. PubMed ID: 7930603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
    Kerr PG; Atkins RC
    Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive activity of 15-deoxyspergualin on normal and autoimmune peripheral blood mononuclear cells.
    Nicoletti F; Borghi MO; Barcellini W; Fain C; Beltrami B; Del Papa N; Schorlemmer HU; Mottola L; Meroni PL
    Eur J Pharmacol; 1996 Sep; 311(2-3):213-20. PubMed ID: 8891602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
    Jung S; Toyka KV; Hartung HP
    Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of deoxyspergualin (NKT-01) on lymphocyte activation in response to alloantigens.
    Yoshikawa Y; Uchida H; Kuroda H; Nakamura T; Obayashi A; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1675-80. PubMed ID: 3058670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Talmadge JE; Takeuchi T
    Int J Immunopharmacol; 1992 May; 14(4):731-7. PubMed ID: 1387869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action.
    Tepper MA; Nadler S; Mazzucco C; Singh C; Kelley SL
    Ann N Y Acad Sci; 1993 Jun; 685():136-47. PubMed ID: 8363218
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of deoxyspergualin on human lymphocyte proliferation in vitro.
    Kerr PG; Atkins RC
    Transplant Proc; 1989 Oct; 21(5):3765-6. PubMed ID: 2815272
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistology of nonrejected deoxyspergualin-treated rat renal allografts.
    Kerr PG; Marshall VC; Atkins RC
    Transplant Proc; 1989 Oct; 21(5):3767-8. PubMed ID: 2815273
    [No Abstract]   [Full Text] [Related]  

  • 15. Flow cytometric analysis of graft-infiltrating lymphocytes in deoxyspergualin-treated rat renal transplants.
    Takeuchi I; Chikaraishi T; Kanagawa K; Tanda K; Seki T; Togashi M; Koyanagi T
    Transplant Proc; 1994 Aug; 26(4):1905-6. PubMed ID: 8066620
    [No Abstract]   [Full Text] [Related]  

  • 16. 15-Deoxyspergualin (a new guanidine-like drug) blocks T lymphocyte proliferation.
    Falk W; Ulrichs K; Müller-Ruchholtz W
    Transplant Proc; 1987 Oct; 19(5):4239-40. PubMed ID: 2960051
    [No Abstract]   [Full Text] [Related]  

  • 17. 15-deoxyspergualin treatment of graft rejection in man: effect on mononuclear cells.
    Borg AJ; Ohlman S
    Transpl Int; 1992 Sep; 5(4):219-25. PubMed ID: 1418313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyspergualin. Mechanism of action studies of a novel immunosuppressive drug.
    Tepper MA
    Ann N Y Acad Sci; 1993 Nov; 696():123-32. PubMed ID: 8109823
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.